Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 21 | 11 | −10 |
| SharesConverted for a 1-for-25 split | 93.8K | 59.1K | −34.6K (−36.9%) |
| Value | $488.2K | $164.2K | −$324.0K (−66.4%) |
New holders (3)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 546 | $1.52K | 0.00% |
| Abound Wealth Management | 27 | $76 | 0.00% |
| Qube Research & Technologies Ltd | 8 | $21 | 0.00% |
Sold out (13)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Vanguard Group Inc | 203,358 | $42.3K |
| Susquehanna International Group, LLP | 180,285 | $37.5K |
| Geode Capital Management, LLC | 137,464 | $28.6K |
| Renaissance Technologies LLC | 107,100 | $22.0K |
| State Street Corp | 52,354 | $10.9K |
| Commonwealth Equity Services, LLC | 36,461 | $8.00K |
| Truist Financial Corp | 33,862 | $7.05K |
| Northern Trust Corp | 29,705 | $6.18K |
| Virtu Financial LLC | 26,473 | $6.00K |
| Two Sigma Securities, LLC | 20,691 | $4.31K |
| Two Sigma Investments, LP | 17,623 | $3.67K |
| Envestnet Asset Management Inc | 13,088 | $2.73K |
| Creative Planning | 10,000 | $2.08K |